CME Group (CME Group) EBIT : $4,313 Mil (TTM As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is CME Group EBIT?

CME Group's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $1,046 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $4,313 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. CME Group's annualized ROC % for the quarter that ended in Dec. 2023 was 2.23%. CME Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 634.33%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. CME Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 5.61%.

CME Group EBIT Historical Data

The historical data trend for CME Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CME Group EBIT Chart

CME Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

2,867.60

2,888.30

3,540.50

3,653.00

4,313.00

CME Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT	Get a 7-Day Free Trial															867.20	1,196.80	1,056.60	1,013.90	1,045.70

Competitive Comparison of CME Group's EBIT

For the Financial Data & Stock Exchanges subindustry, CME Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CME Group's EV-to-EBIT Distribution in the Capital Markets Industry

For the Capital Markets industry and Financial Services sector, CME Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where CME Group's EV-to-EBIT falls into.

CME Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,313 Mil.

CME Group (NAS:CME) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

CME Group's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	3452.8 * ( 1 - 19.03% )	/	( (123140.1	+	128142.2)	/ 2 )
=	2795.73216	/	125641.15
=	2.23 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	125598.2	-	53.8	-	( 2404.3	-	max(0, 87880.5	-	90776.8	+	2404.3	))
=	123140.1

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	129706.1	-	90.6	-	( 3023.7	-	max(0, 93416.9	-	94890.2	+	3023.7	))
=	128142.2

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

CME Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	4182.8	/	( ( (417.3 + max(492, 0))	+	(409.5 + max(-1550.4, 0)) )	/	2 )
=	4182.8	/	( ( 909.3	+	409.5 )	/	2 )
=	4182.8	/	659.4
=	634.33 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(558.4	+	0	+	87814.1)	-	(53.8	+	0	+	87826.7)
=	492

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(535.6	+	0	+	91330.9)	-	(90.6	+	0	+	93326.3)
=	-1550.4

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

CME Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	4313	/	76940.128
	=	5.61 %

CME Group EBIT Related Terms

Thank you for viewing the detailed overview of CME Group's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

CME Group (CME Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » CME Group Inc (NAS:CME) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

CME:Mexico MX4A:Germany MX4A:Germany CHME34:Brazil

Address

20 South Wacker Drive, Chicago, IL, USA, 60606

Website

https://www.cmegroup.com

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX in 2018 it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.

Executives

William R Shepard	director	20 S. WACKER DR, CHICAGO IL 60606
Bryan T Durkin	officer: MD & COO	20 S. WACKER DRIVE, CHICAGO IL 60606
Derek Sammann	officer: Managing Dir Financial Product	20 S. WACKER DRIVE, CHICAGO IL 60606
Dennis Suskind	director	ONE NORTH END AVENUE, WORLD FINANCIAL CENTER, NEW YORK NY 10282
Suzanne Sprague	officer: Sr MD Global Head of Clearing	20 SOUTH WACKER DRIVE, 18S, CHICAGO IL 60606
Timothy Francis Mccourt	officer: Sr MD Global Head Equity & FX	20 S WACKER DRIVE, CHICAGO IL 60606
Elizabeth A Cook	director	20 S. WACKER DRIVE, CHICAGO IL 60606
Martin J Gepsman	director	20 S. WACKER DR, CHICAGO IL 60606
Terrence A Duffy	director	20 S. WACKER DR, CHICAGO IL 60606
Julie Holzrichter	officer: MD Operations	20 S. WACKER DRIVE, CHICAGO IL 60606
Timothy S. Bitsberger	director	20 S. WACKER DRIVE, CHICAGO IL 60606
Julie Winkler	officer: Chief Commercial Officer	20 S. WACKER DR., CHICAGO IL 60606
Daniel R Glickman	director	20 S. WACKER DR, CHICAGO IL 60606
Hilda Harris Piell	officer: MD, Organizational Development	20 S. WACKER DRIVE, CHICAGO IL 60606
Sunil Cutinho	officer: President, CME Clearing	20 S. WACKER DR., CHICAGO IL 60606